“…Hydrophilic polysarcosine (PSar) [23,72] and somewhat lesser hydrophilic poly(N-ethylglycine) (PNEG) [77,78] could be potentially used in the biomedical field. PSar due to nontoxicity [68,79,80], biocompatibility [64,81], non-fouling [82][83][84], low (or no) cytotoxicity [68,72,80,85], electroneutrality [86] is considered as promising alternative to PEG [10,87].…”